Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone
(MedPage Today) -- SAN FRANCISCO -- Combining a PARP inhibitor with an androgen receptor pathway inhibitor as first-line therapy for biomarker-selected patients with metastatic castration-resistant prostate cancer (mCRPC) significantly improved... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 26, 2024 Category: Hematology Source Type: news

Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer
(MedPage Today) -- SAN FRANCISCO -- Men with high-risk localized prostate cancer lived significantly longer with dose-escalated radiation therapy (RT) plus long-term androgen deprivation therapy (ADT), according to long-term follow-up from a... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 26, 2024 Category: Hematology Source Type: news

Two-Stage Screening Strategy for Ovarian Cancer Continues to Show Progress
(MedPage Today) -- A two-stage ovarian cancer screening strategy substantially improved early-stage detection among average-risk postmenopausal women, according to long-term follow-up from a large prospective study. Combining serial CA125 values... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 25, 2024 Category: Hematology Source Type: news

Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer
(MedPage Today) -- A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients with high-risk, biochemically... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 24, 2024 Category: Hematology Source Type: news

Neoadjuvant PD-1 Blockade Boosts pCR Rates in Early Esophageal Cancer
(MedPage Today) -- SAN FRANCISCO -- Adding an investigational PD-1 inhibitor to chemotherapy in the neoadjuvant setting significantly improved pathological complete response (pCR) rates for patients with resectable locally advanced esophageal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 22, 2024 Category: Hematology Source Type: news

Increase in Congenital Syphilis; Decrease in Breast Cancer Mortality
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 20, 2024 Category: Hematology Source Type: news

Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer
(MedPage Today) -- While cancer mortality continues to decline, the number of new cases is projected to top 2 million in 2024, according to the American Cancer Society's annual report on cancer statistics. The FDA approved exagamglogene autotemcel... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 19, 2024 Category: Hematology Source Type: news

Kate Middleton Hospitalized; Sen. Paul Urges Prison for Fauci; COVID Back in Class
(MedPage Today) -- Note that some links may require registration or subscription. Kate Middleton, the Princess of Wales, has been hospitalized following a planned abdominal surgery at a London clinic and canceled all engagements until Easter... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 17, 2024 Category: Hematology Source Type: news

Breast Cancer Mortality Reduced by 58% Over Past Four Decades
(MedPage Today) -- Breast cancer screening and new treatments were associated with a large reduction in mortality from the disease over the past 45 years, according to results from a simulation model-based study. Using four models, the combination... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 16, 2024 Category: Hematology Source Type: news

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk
(MedPage Today) -- Patients with lung cancer treated with epidermal growth factor receptor (EGFR) inhibitors may have an increased risk of new-onset keratitis, a U.S. population-based cohort study showed. Over a 20-year period, 1.12% of patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 13, 2024 Category: Hematology Source Type: news

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA
(MedPage Today) -- A number of common cancers associated with high mortality and cancers more likely to affect Black patients receive disproportionate funding for research and advocacy. (Journal of Clinical Oncology) The FDA declined to approve... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news

COVID Vax and Blood Clots; Cancer Rise in Young Adults; Corpse-Abuse Charge Dropped
(MedPage Today) -- Note that some links may require registration or subscription. In observance of Martin Luther King Day, Morning Break will not be published January 15 and will resume Tuesday January 16. Last year's COVID-19 booster reduced... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news

Exercise Improved Quality of Life for Metastatic Breast Cancer Patients
(MedPage Today) -- Among patients with metastatic breast cancer, those who took part in a 9-month structured exercise program reported less fatigue and improved quality of life compared with patients receiving usual care, results from the PREFERABLE... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy
(MedPage Today) -- Patient-adjusted nitrous oxide (N2O), commonly called laughing gas, did not reduce anxiety associated with transrectal prostate biopsy but significantly reduced pain as compared with standard anesthesia, a small randomized study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news

Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC
(MedPage Today) -- A dose-escalation strategy involving hypofractionated concurrent chemoradiation with adaptive stereotactic ablative radiotherapy (SABR) appeared safe and effective for patients with locally advanced non-small cell lung cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news